|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
German Clinical Trials Register |
|
Last refreshed on:
|
8 April 2024 |
|
Main ID: |
DRKS00006297 |
|
Date of registration:
|
11/07/2014 |
|
Prospective Registration:
|
Yes |
|
Primary sponsor: |
|
|
Public title:
|
Dynamic of tumor hypoxia before, during and after radiotherapy as assessed by biomarker analysis in patient serum
|
|
Scientific title:
|
Dynamic of tumor hypoxia before, during and after radiotherapy as assessed by biomarker analysis in patient serum |
|
Date of first enrolment:
|
04/11/2014 |
|
Target sample size:
|
300 |
|
Recruitment status: |
Recruiting |
|
URL:
|
http://drks.de/search/en/trial/DRKS00006297 |
|
Study type:
|
observational |
|
Study design:
|
Allocation: ; Masking: ; Control: ; Assignment: ; Study design purpose: basic science
|
|
Phase:
|
|
|
|
Countries of recruitment
|
|
Switzerland
| | | | | | | |
|
Contacts
|
|
Name:
|
Oliver
Riesterer |
|
Address:
|
Rämistrasse 100
8091
Zürich
Switzerland |
|
Telephone:
|
+41 (0) 44 255 3748 |
|
Email:
|
oliver.riesterer@usz.ch |
|
Affiliation:
|
Klinik für Radio-OnkologieUniversitätsSpital Zürich |
|
|
Name:
|
Oliver
Riesterer |
|
Address:
|
Rämistrasse 100
8091
Zürich
Switzerland |
|
Telephone:
|
+41 (0) 44 255 3748 |
|
Email:
|
oliver.riesterer@usz.ch |
|
Affiliation:
|
Klinik für Radio-OnkologieUniversitätsSpital Zürich |
| |
|
Key inclusion & exclusion criteria
|
Inclusion criteria: NSCLC treated with stereotactic body radiotherapy or nomally fractionated radiotherapy. In addition, patients with cancers of different origin and treated with SBRT may also be included for biomarker analysis.
Exclusion criteria: Postoperative radiotherapy. Pregnant or lactating women.
Age minimum:
18 Years
Age maximum:
None
Gender:
All
|
|
Health Condition(s) or Problem(s) studied
|
|
C30-C39
|
|
Malignant neoplasms of respiratory and intrathoracic organs
|
Cancers of different origin
C30-C39
|
|
Intervention(s)
|
|
Group 1: Asservation of blood serum, plasma and whole blood at different time points before, during and after end of radiotherapy for biomarker analysis
|
|
Primary Outcome(s)
|
|
Explorative biomarker analysis in blood serum, plasma and whole blood before, during and after radiotherapy
|
|
Source(s) of Monetary Support
|
|
KFSP Tumor Oxygenation, University Hospital Zurich
|
|
Ethics review
|
Status: Approved
Approval date: 22/10/2013
Contact:
Kantonale Ethikkommission Zürich [Kantonale Ethikkommission (KEK) Zürich]
|
|